BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.24% |
| 2 | Financials | 6.85% |
| 3 | Healthcare | 5.31% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KSU
3101
CALL
DELISTED
Kansas City Southern
KSU
| $108K | ﹤0.01% |
4
| – | – |
|
|
ATRS
3102
DELISTED
Antares Pharma, Inc.
ATRS
| $108K | ﹤0.01% |
29,607
+23,136
| +358% | +$93.5K |
|
3103
Regional Management Corp
RM
$301M
| $107K | ﹤0.01% |
1,846
+1,529
| +482% | +$84.3K |
|
|
AKRO
3104
DELISTED
Akero Therapeutics
AKRO
| $107K | ﹤0.01% |
4,798
+3,857
| +410% | +$87.3K |
|
3105
Axogen
AXGN
$2.58B
| $107K | ﹤0.01% |
6,786
+5,501
| +428% | +$98.8K |
|
|
RDUS
3106
DELISTED
Radius Health, Inc.
RDUS
| $107K | ﹤0.01% |
8,619
+6,849
| +387% | +$98.7K |
|
3107
i3 Verticals
IIIV
$325M
| $107K | ﹤0.01% |
4,407
+3,592
| +441% | +$104K |
|
3108
Adaptive Biotechnologies
ADPT
$3.89B
| $106K | ﹤0.01% |
3,123
+1,447
| +86% | +$52.3K |
|
3109
Citizens & Northern Corp
CZNC
$466M
| $106K | ﹤0.01% |
4,200
+2,225
| +113% | +$55.4K |
|
3110
CALL
Colgate-Palmolive
CL
$74.1B
| $106K | ﹤0.01% |
+14
| New | +$1.11K |
|
3111
Safe Bulkers
SB
$781M
| $106K | ﹤0.01% |
20,440
+8,663
| +74% | +$33.4K |
|
3112
MVB Financial
MVBF
$397M
| $106K | ﹤0.01% |
2,464
+1,310
| +114% | +$53.4K |
|
3113
Altimmune
ALT
$560M
| $106K | ﹤0.01% |
9,330
+5,909
| +173% | +$71.9K |
|
3114
NRC Health Common Stock
NRC
$471M
| $105K | ﹤0.01% |
2,495
+2,005
| +409% | +$101K |
|
3115
FRP Holdings
FRPH
$425M
| $105K | ﹤0.01% |
3,746
+1,924
| +106% | +$55.3K |
|
3116
Tootsie Roll Industries
TR
$3.02B
| $105K | ﹤0.01% |
3,987
-662
| -14% | -$18.7K |
|
3117
Capital City Bank Group
CCBG
$898M
| $105K | ﹤0.01% |
4,229
+1,941
| +85% | +$46.2K |
|
3118
Frontdoor
FTDR
$5.83B
| $105K | ﹤0.01% |
2,497
+766
| +44% | +$35K |
|
3119
Miller Industries
MLR
$640M
| $105K | ﹤0.01% |
3,073
+1,805
| +142% | +$66.6K |
|
|
HTB
3120
HomeTrust Bancshares
HTB
$837M
| $104K | ﹤0.01% |
3,733
+1,837
| +97% | +$50.5K |
|
|
GTHX
3121
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $104K | ﹤0.01% |
7,772
+6,430
| +479% | +$105K |
|
3122
Funko
FNKO
$335M
| $104K | ﹤0.01% |
5,719
+4,630
| +425% | +$87.4K |
|
|
VBIV
3123
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $104K | ﹤0.01% |
1,115
+796
| +250% | +$75.6K |
|
3124
American Superconductor
AMSC
$1.53B
| $104K | ﹤0.01% |
7,137
+4,433
| +164% | +$61.4K |
|
3125
RCI Hospitality Holdings
RICK
$230M
| $103K | ﹤0.01% |
1,508
+1,184
| +365% | +$77.4K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.